Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors
Authors
Keywords
Systemic Lupus Erythematosus, Plasma Cell, Systemic Lupus Erythematosus Patient, Bortezomib, Belimumab
Journal
ARTHRITIS RESEARCH & THERAPY
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-02-25
DOI
10.1186/s13075-015-0551-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Response to letter by Aramugakaniet al
- (2014) Gianfranco Ferraccioli et al. ANNALS OF THE RHEUMATIC DISEASES
- A3.26 Proteasome inhibition with bortezomib in refractory SLE inhibits type I interferon and depletes plasma cells but does not inhibit their regeneration
- (2014) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Response to: ‘Which B-cell subset should we target in lupus?’ by Ferraccioli and Houssiau
- (2014) Gururaj Arumugakani et al. ANNALS OF THE RHEUMATIC DISEASES
- Cutting Edge: The Dependence of Plasma Cells and Independence of Memory B Cells on BAFF and APRIL
- (2014) M. J. Benson et al. JOURNAL OF IMMUNOLOGY
- Long-Term B Cell Depletion in Murine Lupus Eliminates Autoantibody-Secreting Cells and Is Associated with Alterations in the Kidney Plasma Cell Niche
- (2014) W. Wang et al. JOURNAL OF IMMUNOLOGY
- Which B-cell subset should we target in lupus?
- (2013) Gianfranco Ferraccioli et al. ANNALS OF THE RHEUMATIC DISEASES
- Autoantibodies from long-lived ‘memory’ plasma cells of NZB/W mice drive immune complex nephritis
- (2013) Qingyu Cheng et al. ANNALS OF THE RHEUMATIC DISEASES
- Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens
- (2013) Sung-Hoon Jung et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus
- (2013) E. M. Ginzler et al. JOURNAL OF RHEUMATOLOGY
- Long-Lived Plasma Cells in Autoimmunity: Lessons from B-Cell Depleting Therapy
- (2013) Matthieu Mahévas et al. Frontiers in Immunology
- Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus
- (2012) William Stohl et al. ARTHRITIS AND RHEUMATISM
- Bone marrow of NZB/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: Implications for the treatment of autoimmunity
- (2012) Imtiaz M. Mumtaz et al. JOURNAL OF AUTOIMMUNITY
- B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells
- (2012) Matthieu Mahévas et al. JOURNAL OF CLINICAL INVESTIGATION
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- High frequency of autoantibody-secreting cells and long-lived plasma cells within inflamed kidneys of NZB/W F1 lupus mice
- (2011) Charlotte Starke et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
- (2011) Falk Hiepe et al. Nature Reviews Rheumatology
- Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus
- (2010) Kai W. Bekar et al. ARTHRITIS AND RHEUMATISM
- A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
- (2009) Daniel J. Wallace et al. ARTHRITIS AND RHEUMATISM
- Effect of long-term belimumab treatment on b cells in systemic lupus erythematosus: Extension of a phase II, double-blind, placebo-controlled, dose-ranging study
- (2009) Annett M. Jacobi et al. ARTHRITIS AND RHEUMATISM
- Bortezomib-induced peripheral neuropathy in multiple myeloma: A comparison between previously treated and untreated patients
- (2009) Alessandro Corso et al. LEUKEMIA RESEARCH
- Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system
- (2008) T. Alexander et al. BLOOD
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- Systemic Lupus Erythematosus
- (2008) Anisur Rahman et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now